CardioNet Announces Launch of Clinical Indicator for Sleep Disorders
May 14 2009 - 5:00PM
Business Wire
CardioNet, Inc. (NASDAQ:BEAT) today announced the launch of
SomNet �, a new clinical indicator available in the Company�s
existing Mobile Cardiac Outpatient Telemetry� (MCOT�) system.
Because many patients with cardiac disorders also suffer from
common sleep disorders like sleep apnea, CardioNet believes that
SomNet has the potential to identify patients with a high
likelihood of such sleep disorders by measuring cyclic variation of
heart rate (CVHR), a rhythm that is caused by repeated arousals
from sleep due to such disorders. SomNet�s utility is based on data
presented at the Heart Rhythm Society�s (HRS) 30th Annual
Scientific Sessions in Boston.
�There is a high prevalence of sleep disorders like sleep apnea
in the cardiovascular and arrhythmia population,� said Randy
Thurman, CEO of CardioNet. �The data collected by SomNet is
extremely valuable information that can be captured from our
existing MCOT ECG signal. If clinically appropriate, physicians may
choose to refer patients with CVHR patterns to sleep centers for
further diagnostic testing, to determine if they have sleep apnea
or another serious sleep disorder.�
In an 80-patient study presented today at HRS, Phyllis K. Stein,
Ph.D., Research Associate Professor of Medicine at Washington
University School of Medicine, found that automated identification
of clinically relevant CVHR is feasible using CardioNet�s MCOT
system. The study compared MCOT automatic analysis of CVHR patterns
versus a human expert�s direct analysis of plots of HR patterns for
measuring clear (large amplitude) CVHR. Findings showed similar
specificity and positive predictive value measures between MCOT and
human expert analysis, with slightly lower sensitivity measures for
the automated analysis.
�Although slightly less sensitive than more labor intensive
human overreading, the MCOT system and SomNet may provide a
platform for efficiently identifying patients with severe sleep
disorders, like sleep apnea, in a large population,� said Dr.
Stein.
About CardioNet,
Inc.
CardioNet, Inc. is the leading provider of ambulatory,
continuous, real-time outpatient management solutions for
monitoring relevant and timely clinical information regarding an
individual's health. CardioNet's initial efforts are focused on the
diagnosis and monitoring of cardiac arrhythmias, or heart rhythm
disorders, with a solution that it markets as Mobile Cardiac
Outpatient Telemetry� (MCOT�). More information can be found at
http://www.cardionet.com.
Forward Looking
Statements
This press release includes certain forward-looking statements
within the meaning of the �Safe Harbor� provisions of the Private
Securities Litigation Reform Act of 1995 regarding, among other
things, our growth prospects, the prospects for our products and
our confidence in the Company�s future. These statements may be
identified by words such as �expect,� �anticipate,� �estimate,�
�intend,� �plan,� �believe,� �promises� and other words and terms
of similar meaning. Such forward-looking statements are based on
current expectations and involve inherent risks and uncertainties,
including important factors that could delay, divert, or change any
of them, and could cause actual outcomes and results to differ
materially from current expectations. These factors include, among
other things, the success of our sales and marketing initiatives,
our ability to attract and retain talented executive management and
sales personnel, our ability to identify acquisition candidates,
acquire them on attractive terms and integrate their operations
into our business, the commercialization of new products, market
factors, internal research and development initiatives, partnered
research and development initiatives, competitive product
development, changes in governmental regulations and legislation,
changes to reimbursement levels for our products, the continued
consolidation of payors, acceptance of our new products and
services and patent protection and litigation. For further details
and a discussion of these and other risks and uncertainties, please
see our public filings with the Securities and Exchange Commission,
including our latest periodic reports on Form 10-K and 10-Q. We
undertake no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events,
or otherwise.
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Sep 2024 to Oct 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Oct 2023 to Oct 2024